Replies to post #71 on China Biologic Products, Inc. (CBPO)

[surf1944]

6:24AM On The Wires (WIRES) China Biologic Products (CBPO) announced that its indirectly owned subsidiary, Shandong Taibang Biological Products, recently received approval from the China State Food and Drug Administration to begin clinical trials for its human fibrinogen to be used to treat congenital fibrinogen deficiency and acquired fibrinogen deficiency.